Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

RioCan Real Estate Investment Trust T.REI.UN

Alternate Symbol(s):  RIOCF

RioCan Real Estate Investment Trust is a Canada-based real estate investment trust. The Company owns, manages and develops retail-focused, mixed-use properties. Its portfolio includes leasing, development, and residential. The Company’s properties are held by various tenants, such as grocery, pharmacy, liquor, personal services, and specialty and value retailers. Its portfolio comprises approximately 187 properties with an aggregate net leasable area of approximately 33 million square feet. Its properties include 1293 Bloor Street West; 145 Woodbridge Avenue; 1556 Bank Street; 1650 -1660 Carling Avenue; 1860 Bayview; 1946 Robertson Road; 2422 Fairview Street, and others. Its properties for commercial lease, including grocery anchored, open air, mixed-use/urban, and enclosed centers. Its residential brand, RioCan Living, delivers purpose-built rental units and condos. 1293 Bloor Street West is located at the intersection of Lansdowne Ave & Bloor Street in Toronto.


TSX:REI.UN - Post by User

Comment by CANCDNon Dec 22, 2020 1:59pm
48 Views
Post# 32162047

RE:RE:THE BIG SHORT

RE:RE:THE BIG SHORTYup and people are stupid if they believe that. Mutations dont cause a 95% effective vaccine to go to 0%. In fact, the mutation (this is #21 by the way that is being tested against the vaccine) is JUST as likely to INCREASE efficacy as it is to decrease efficacy. Its not an all or nothing proposition. It might come back that the vaccine is 5% LESS effective , or it could be 5% MORE effective (unlikely 100%). 

Keep shorting.

not one crediable vaccinologist actually believes this will affect the vaccine what so ever. all 20+ previous mutations are easily managed by the vaccine. Will mRNA vaccine manufacture slightly adjusted formula,,, possibily, but same happens every year with flu vaccines, and those are only 60% effective at best. 

Keep up the panic porn

BlueGuitar1 wrote: Only a fool ignores "thenewsnake".  He has some good insights.

Concerning what he just said, the mutation is in the receptor binding location which could be very bad for the new vaccines.  Specifically it is the animo-acid in the 501 position and has changed from Asparagine (N) to Tyrosine (Y).  The mutation is therefore called N501Y, or N to Y in position 501.  If there is another mutation near this position, the new vaccine probably will not work.  This mutation is in Brazil, Australia, UK, Denmark, and Netherlands now.  It is probably in Canada. I will still say that we will have a tough next 6 months.  The vaccine will not help in the first and second quarters. 

Hope that helps a bit in making your own financial decisions.  Do your own DD. 

thenewsnake wrote:

Is definitely on this turd- drifting lower by the second.  Watch a headline come out "vaccine proven not to be effective against new strain" and BAM just like that we're down an additional 20%!!!!!!!!!!!!




<< Previous
Bullboard Posts
Next >>